Monitoring clinical changes in patients with heart failure: a comparison of methods.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Heart Journal

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2004.12.010PMID 16209970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).

  2002cited by this paper
• Methods to explain the clinical significance of health status measures.

  2002cited by this paper
• Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms.

  2002cited by this paper
• A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission.

  2002cited by this paper
• Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life.

  2002cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper
• ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary

  2002cited by this paper
• Continuous Hemodynamic Monitoring in Heart Failure

  2002cited by this paper
• B-type natriuretic peptide -- a window to the heart.

  2002cited by this paper
• The benefit of implementing a heart failure disease management program.

  2001cited by this paper
• Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

  2000cited by this paper
• Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project.

  2000cited by this paper
• Identifying meaningful intra-individual change standards for health-related quality of life measures.

  2000cited by this paper
• Heart failure disease management: a critical review.

  1999cited by this paper
• Disease management interventions to improve outcomes in congestive heart failure.

  1997cited by this paper
• A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

  1996cited by this paper
• Quality of life and pharmacoeconomics in clinical trials

  1996cited by this paper
• A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.

  1995cited by this paper
• Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

  1994cited by this paper
• Measurement of health-related quality of life in heart failure.

  1993cited by this paper
• Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group.

  1992cited by this paper
• Measurement of health status. Ascertaining the minimal clinically important difference.

  1989cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire

  1987cited by this paper
• The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

  1985cited by this paper
• Regression models for prognostic prediction: advantages, problems, and suggested solutions.

  1985cited by this paper

• Comparing Clinical Outcomes of Patients With a Small Versus Large Annulus After Newer-Generation Balloon-Expandable Transcatheter Aortic Valve Replacement.

  2026cites this paper
• Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study.

  2026cites this paper
• Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II.

  2026cites this paper
• Early Outcomes of Off-Label Transcatheter Tricuspid Valve Repair/Replacement in the STS/ACC TVT Registry.

  2026cites this paper
• HEART Camp Connect—Promoting adherence to exercise in adults with heart failure with preserved ejection fraction

  2025cites this paper
• Reliability of a German version of the Kansas City Cardiomyopathy Questionnaire (KCCQ) administered via telephone

  2025cites this paper
• A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy

  2025cites this paper
• Patient-Reported Outcomes as End Points in Heart Failure Trials.

  2025cites this paper
• Minimally Important Kansas City Cardiomyopathy Questionnaire Changes Across the Spectrum of Heart Failure Severity.

  2025cites this paper
• Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement.

  2025cites this paper
• Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes

  2025cites this paper
• Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12.

  2025cites this paper
• Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention

  2025cites this paper
• Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.

  2025cites this paper
• Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology

  2025cites this paper
• Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.

  2025cites this paper
• Quality of Life after Mitral Valve Surgery. Results from the Cardiothoracic Surgical Trials Network.

  2025cites this paper
• Short-term effects of exercise training program on patients with compensated chronic heart failure

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure.

  2025cites this paper
• Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints

  2025influential citation
• The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

  2025cites this paper
• Impact of adverse social determinants on quality of life and satisfaction after left ventricular assist device: A Southern single-center pilot experience.

  2025cites this paper
• Impact of Vutrisiran on Functional Capacity and Quality of Life in Transthyretin Amyloidosis With Cardiomyopathy.

  2025cites this paper
• Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology.

  2025cites this paper
• SHengXIaN-QuYu DEcoction in the Treatment of Heart Failure with Reduced and Mildly-Reduced Ejection Fraction (SHINE-HF): rationale and design for a multicenter randomized controlled trial

  2025cites this paper
• Isometric exercise training in patients with heart failure with preserved ejection fraction: A randomised controlled study.

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis

  2025cites this paper
• Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC

  2025cites this paper
• Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year Results.

  2025cites this paper
• Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF Registry

  2024cites this paper
• Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum.

  2024cites this paper
• Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes.

  2024cites this paper
• Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials

  2024cites this paper
• Perceived Economic Burden, Mortality, and Health Status in Patients With Heart Failure

  2024cites this paper
• Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.

  2024cites this paper
• Patisiran in Patients with Transthyretin Cardiac Amyloidosis. Reply.

  2024cites this paper
• An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program

  2024cites this paper
• Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

  2024cites this paper
• Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.

  2024cites this paper
• Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial

  2024cites this paper
• Postoperative quality of life and pain after upper hemisternotomy and conventional median sternotomy for aortic valve replacement: results of a randomized clinical trial

  2024cites this paper
• The impact of ventricular remodeling on quality-of-life outcomes after Transcatheter aortic valve replacement.

  2024cites this paper
• The FINE ART of Interpreting Health Status Benefits in Clinical Trials.

  2024cites this paper
• Integration of Palliative Care into Heart Failure Care: Consensus-Based Recommendations from the Heart Failure Society of America.

  2024cites this paper
• Interpreting Population Mean Treatment Effects in the Kansas City Cardiomyopathy Questionnaire: A Patient-Level Meta-Analysis.

  2024cites this paper
• Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.

  2024cites this paper
• Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol

  2024cites this paper
• Heart Failure Prediction using Machine Learning Techniques: A Comparative Analysis

  2024cites this paper
• Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis

  2024cites this paper
• Shared Medical Appointments in Heart Failure for Post Acute Care Follow‐Up: A Randomized Controlled Trial

  2024cites this paper
• Time to assess more than prognosis: advancements and challenges in transcatheter tricuspid valve interventions

  2024cites this paper
• Mitral Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation With Preserved Left Ventricular Function.

  2024cites this paper
• Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy

  2024cites this paper
• Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.

  2023cites this paper
• Accelerometer-Measured Physical Activity in Patients with Heart Failure and Reduced Ejection Fraction: Determinants and Relationship with Patient-Reported Health Status.

  2023cites this paper
• Is Sacubitril/Valsartan a Superior Agent in Heart Failure With Reduced Ejection Fraction? A Review of Randomized Comparative Trials

  2023cites this paper
• Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure

  2023cites this paper
• Effect of Daily Activity Record-Based Self-monitoring Intervention on the Perception of Physical Sensations in Patients With Chronic Heart Failure

  2023cites this paper
• Psychometric Properties of the Kansas City Cardiomyopathy Questionnaire in a Surgical Population of Patients With Aortic Valve Stenosis.

  2023cites this paper
• Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve Replacement.

  2023cites this paper
• Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.

  2023cites this paper
• Clinical Utility of Patient-Reported Outcome Instruments in the Management of Pulmonary Hypertension: A Systematic Review.

  2023cites this paper
• The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population

  2023cites this paper
• Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.

  2023cites this paper
• Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

  2023cites this paper
• Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM

  2023cites this paper
• Clinical effects of cognitive behavioral therapy in heart failure patients: a meta-analysis of randomized controlled trials

  2023cites this paper
• Percutaneous ventricular assist device for higher‐risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study

  2023cites this paper
• Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia

  2023cites this paper
• Changing health related quality of life and outcomes in heart failure by age, sex and subtype

  2023cites this paper
• Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study.

  2023cites this paper
• Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study

  2023cites this paper
• Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials

  2023cites this paper
• The Impact of Severe Ventricular Remodeling on Quality-of-Life Outcomes after Transcatheter Aortic Valve Replacement

  2023cites this paper
• Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.

  2023cites this paper
• Left atrium decompression devices across the spectrum of ejection fraction in heart failure: an updated systematic review and meta-regression analysis

  2023cites this paper
• Clinical Application of Six-Minute Walk Test in Cardiac Rehabilitation

  2023cites this paper
• Development and validation of echocardiography-based machine-learning models to predict mortality

  2023cites this paper
• Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives

  2023cites this paper
• Getting into Light Exercise (GENTLE-HF) for Patients with Heart Failure: The Design and Methodology of a Live-Video Group Exercise Study.

  2023cites this paper
• Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.

  2023cites this paper
• Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis

  2023cites this paper
• Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery.

  2023cites this paper
• Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.

  2023cites this paper
• Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation.

  2023cites this paper
• Health status across major subgroups of patients with heart failure and preserved ejection fraction

  2023cites this paper
• Use of patient‐reported outcomes in heart failure: from clinical trials to routine practice

  2023cites this paper
• Measuring Clinically Important Changes in Patients with Heart Failure.

  2023cites this paper
• Association Between Caregiver Burden and Patient Recovery After Left Ventricular Assist Device Implantation

  2023cites this paper
• Taking Care of Us© (TCU) study protocol: feasibility and acceptability of a dyadic intervention for couples living with heart failure

  2023cites this paper
• Outcomes of Transcatheter Aortic Valve Replacement in Asymptomatic or Minimally Symptomatic Aortic Stenosis.

  2023cites this paper
• Patient-Reported Status and Heart Failure Outcomes in Asia by Sex, Ethnicity, and Socioeconomic Status

  2023cites this paper
• Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study PRESS

  2022cites this paper
• on mortality quality of life in patients with a history of cancer undergoing transcatheter aortic valve replacement.

  2022cites this paper
• Circulation: Cardiovascular Interventions

  2022cites this paper
• Automated digital counselling with social network support as a novel intervention for patients with heart failure: protocol for randomised controlled trial

  2022cites this paper
• Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status.

  2022cites this paper
• Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion

  2022cites this paper